Iter Investments

What is Iter Investments?

Iter Investments is a venture capital firm that directs its investments towards the burgeoning psychedelic industry with the aim of revolutionizing mental and behavioral health. With a minimum investment capacity of $100,000 and a maximum of $5,000,000, the fund primarily engages in Seed to Series A financing rounds, focusing their investment efforts within a sweet spot of $1,500,000.

They manage assets totaling $20,000,000, signaling a significant commitment to the sectors they target. Particularly, Iter Investments is deeply involved in the BioTech, FinTech & Financial Services, HealthTech & Fitness, Impact, Healthcare & Wellness, Consumer, and Pharmaceutical & Medicine industries.

What sets Iter Investments apart is their belief in the transformative potential of innovative psychedelic treatments and technologies to make high-quality, cost-effective mental healthcare and wellness accessible to all. They identify as a diverse group of builders, investors, lawyers, scientists, physicians, clinicians, and technologists, uniting to support entrepreneurs with the vision and capability to impact global mental health, well-being, and humanity at large. Their portfolio includes a range of early-stage investments in the psychedelic space across multiple sectors of the value chain, testament to their active and hands-on approach.

With experienced industry operators and executives on the team, Iter is positioned to offer unparalleled investment opportunity sourcing, due diligence, and portfolio management to ensure the success of their investments and to bend the care and cost curves in healthcare forever.